MXPA04005346A - Uso de microorganismos para una distribucion dirigida de sustancias a partes especificas del intestino. - Google Patents

Uso de microorganismos para una distribucion dirigida de sustancias a partes especificas del intestino.

Info

Publication number
MXPA04005346A
MXPA04005346A MXPA04005346A MXPA04005346A MXPA04005346A MX PA04005346 A MXPA04005346 A MX PA04005346A MX PA04005346 A MXPA04005346 A MX PA04005346A MX PA04005346 A MXPA04005346 A MX PA04005346A MX PA04005346 A MXPA04005346 A MX PA04005346A
Authority
MX
Mexico
Prior art keywords
organisms
micro
specific parts
gut
substances
Prior art date
Application number
MXPA04005346A
Other languages
English (en)
Inventor
Zink Ralf
Original Assignee
Nestle Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nestle Sa filed Critical Nestle Sa
Publication of MXPA04005346A publication Critical patent/MXPA04005346A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6901—Conjugates being cells, cell fragments, viruses, ghosts, red blood cells or viral vectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Cell Biology (AREA)
  • Hematology (AREA)
  • Virology (AREA)
  • Nutrition Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La presente invencion pertenece al uso de microorganismos, en particular bacterias de acido lactico por ejemplo como Lactobacilos y Bifidobacterias para entregar sustancias beneficas al receptor en partes especificas de su tracto gastrointestinal. En particular, la presente invencion se refiere a un portador ingerible que contiene microorganismos con tales propiedades, y al uso del mismo para apoyar el bienestar de individuos y para el tratamiento y/o profilaxis de enfermedades.
MXPA04005346A 2001-12-11 2002-11-25 Uso de microorganismos para una distribucion dirigida de sustancias a partes especificas del intestino. MXPA04005346A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP01129563A EP1319410A1 (en) 2001-12-11 2001-12-11 Use of micro-organisms for a directed delivery of substances to specific parts of the gut
PCT/EP2002/013244 WO2003053474A2 (en) 2001-12-11 2002-11-25 Use of micro-organisms for a directed delivery of substances to specific parts of the gut

Publications (1)

Publication Number Publication Date
MXPA04005346A true MXPA04005346A (es) 2004-09-27

Family

ID=8179510

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA04005346A MXPA04005346A (es) 2001-12-11 2002-11-25 Uso de microorganismos para una distribucion dirigida de sustancias a partes especificas del intestino.

Country Status (16)

Country Link
US (1) US20050084479A1 (es)
EP (2) EP1319410A1 (es)
JP (1) JP2005513111A (es)
KR (1) KR20040063942A (es)
CN (1) CN100450550C (es)
AU (1) AU2002352135A1 (es)
BR (1) BR0214835A (es)
CA (1) CA2469894A1 (es)
IL (1) IL161658A0 (es)
MX (1) MXPA04005346A (es)
NO (1) NO20042152L (es)
NZ (1) NZ533376A (es)
PL (1) PL370439A1 (es)
RU (1) RU2311929C2 (es)
WO (1) WO2003053474A2 (es)
ZA (1) ZA200405453B (es)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004001020A2 (en) * 2002-06-19 2003-12-31 Vlaams Interuniversitair Instituut Voor Biotechnologie Vzw Methods and means to promote gut absorption
US8871266B2 (en) * 2003-10-01 2014-10-28 Commonwealth Scientific & Industrial Research Organisation Probiotic storage and delivery
US8877178B2 (en) 2003-12-19 2014-11-04 The Iams Company Methods of use of probiotic bifidobacteria for companion animals
US20050158294A1 (en) 2003-12-19 2005-07-21 The Procter & Gamble Company Canine probiotic Bifidobacteria pseudolongum
DK1880001T3 (da) 2005-05-31 2011-09-12 Iams Company Feline probiotiske lactobacilli
CA2607949C (en) 2005-05-31 2012-09-25 Thomas William-Maxwell Boileau Feline probiotic bifidobacteria
JP5410759B2 (ja) 2005-11-29 2014-02-05 アクトジェニックス・エヌブイ 抗原に対する粘膜寛容の誘導
EP2774621B1 (en) 2007-01-25 2018-01-24 Intrexon Actobiotics NV Treatment of immune disease by mucosal delivery of antigens
AU2008211600B8 (en) 2007-02-01 2014-02-13 Mars, Incorporated Method for decreasing inflammation and stress in a mammal using glucose antimetabolites, avocado or avocado extracts
US9771199B2 (en) * 2008-07-07 2017-09-26 Mars, Incorporated Probiotic supplement, process for making, and packaging
WO2010002241A1 (en) * 2008-06-30 2010-01-07 N.V. Nutricia Nutritional composition for infants delivered via caesarean section
EP2140772A1 (en) * 2008-07-03 2010-01-06 Nestec S.A. Temperature-induced delivery of nutrients by micro-organisms in the gastrointestinal tract
US9232813B2 (en) * 2008-07-07 2016-01-12 The Iams Company Probiotic supplement, process for making, and packaging
US10104903B2 (en) 2009-07-31 2018-10-23 Mars, Incorporated Animal food and its appearance
HUE039577T2 (hu) * 2011-06-01 2019-01-28 Intrexon Actobiotics Nv Policisztronos expressziós rendszer baktériumokhoz
KR102219239B1 (ko) * 2018-12-12 2021-02-24 피부생명공학센터 주식회사 레스베라트롤이 세포내에 축적되어 있는 미생물 제제 및 이의 제조방법
CN113403375A (zh) * 2021-02-20 2021-09-17 北京金则医学检验实验室有限公司 一种用于预测儿童肥胖症的组合物及其应用

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5830463A (en) * 1993-07-07 1998-11-03 University Technology Corporation Yeast-based delivery vehicles
US5733568A (en) * 1993-12-03 1998-03-31 Lafor Laboratories Limited Micro-encapsulated lactobacilli for medical applications
CN1153002A (zh) * 1995-12-29 1997-07-02 中国科学院上海细胞生物学研究所 抗人体消化道病原微生物免疫牛奶
WO1997029763A1 (en) * 1996-02-14 1997-08-21 The Procter & Gamble Company Urogenital and intestinal disorder compositions comprising a substance derived from plant species of the ericaceae family and a lactic acid bacteria growth factor
CN1121817C (zh) * 1996-02-28 2003-09-24 中国科学院上海细胞生物学研究所 抗人体消化道病原微生物免疫乳制品
AT406166B (de) * 1997-12-30 2000-03-27 Erber Erich Kg Mikroorganismus, verfahren zur gewinnung desselben sowie futtermittelzusatz
JPH11199495A (ja) * 1998-01-10 1999-07-27 Nichinichi Seiyaku Kk 腸溶性カプセルを用いた抗アレルギー剤
JPH11302158A (ja) * 1998-04-16 1999-11-02 Oruto Corporation:Kk 腸溶性シームカプセルを用いた整腸作用を有する健康食品
US6368591B2 (en) * 1998-05-15 2002-04-09 Shanghai Sine Pharmaceutical Corporation Ltd. Beneficial microbe composition, new protective materials for the microbes, method to prepare the same and uses thereof
US6713073B1 (en) * 1998-07-24 2004-03-30 Megan Health, Inc. Method of vaccination of newly hatched poultry
EP1084709A1 (en) * 1999-09-17 2001-03-21 Nederlandse Organisatie Voor Toegepast-Natuurwetenschappelijk Onderzoek Tno Oral recombinant lactobacilli vaccines
JP2004514424A (ja) * 2000-09-25 2004-05-20 ソシエテ　デ　プロデユイ　ネツスル　ソシエテ　アノニム アレルギー反応を起こす個人の傾向を減少させることができる乳酸菌
CA2607949C (en) * 2005-05-31 2012-09-25 Thomas William-Maxwell Boileau Feline probiotic bifidobacteria

Also Published As

Publication number Publication date
EP1455836A2 (en) 2004-09-15
CN100450550C (zh) 2009-01-14
WO2003053474A3 (en) 2004-02-19
JP2005513111A (ja) 2005-05-12
KR20040063942A (ko) 2004-07-14
RU2004121169A (ru) 2005-06-10
US20050084479A1 (en) 2005-04-21
EP1319410A1 (en) 2003-06-18
WO2003053474A2 (en) 2003-07-03
NZ533376A (en) 2006-05-26
PL370439A1 (en) 2005-05-30
CN1599626A (zh) 2005-03-23
RU2311929C2 (ru) 2007-12-10
IL161658A0 (en) 2004-09-27
NO20042152L (no) 2004-09-08
ZA200405453B (en) 2005-07-08
AU2002352135A1 (en) 2003-07-09
CA2469894A1 (en) 2003-07-03
BR0214835A (pt) 2004-11-03

Similar Documents

Publication Publication Date Title
MXPA04005346A (es) Uso de microorganismos para una distribucion dirigida de sustancias a partes especificas del intestino.
TW200514847A (en) Lactic acid bacteria having mucosal immunopotentiation effect
ATE534396T1 (de) Probiotische mikroorganismen zur verbesserung der muskulären funktion
AU2002350530A1 (en) Composition comprising a lactobacillus pentosus strain and uses thereof
EP2255815A3 (en) Nutritional Composition
EP1567660A4 (en) Merging fermented ginseng, lactose, yoghurt, and lactose used in the production of milk lactobacteria
MXPA03002957A (es) Uso de bacteria probiotica de acido lactico para balancear el sistema inmune de la piel.
NZ599302A (en) Preventing diseases in infants delivered via caesarean section
HK1061501A1 (en) Combination of probiotics
BG103228A (en) Antistress medicaments and functional foods having antistress effect
HK1111883A1 (en) Use of a composition for preventing or treating respiratory infections and acute otitis media in infants
SI1312667T1 (sl) Probiotiäśni produkti, ki vsebujejo sev l. salivarius
ZA200703166B (en) Composition comprising lactic acid and lactoferrin
EP2241196A3 (en) Nutritional supplement comprising oligosaccharides and cysteine for treating hiv
MXPA03001673A (es) Bacteria de acido lactico capaz de reducir una tendencia individual a desarrollar reacciones alergicas.
WO2007015132A3 (en) Use of specific lactic bacteria for the preparation of immunomodulating compositions
AP1563A (en) Lactic acid bacteria for the treatment and /or prophylaxis of giardiasis.
EP1541672A4 (en) COMPOSITION FOR PROLIFERATING LACTOBACILLUS CASEI SUBSP. CASEI
AU5069500A (en) Use of lactic acid bacteria in the preparation of fermented milks for the treatment of depressed immunity levels
EE05412B1 (et) Bifidobacterium'i perekonna probiootiliste tvede skriinimise meetod
AU2003293804A1 (en) Dental material containing bacteriostatic and/or bactericidal substances
ITMI20032391A1 (it) Olive da mensa contenenti microrganismi probiotici.
MD20010076A (ro) Preparat microbian sanogenic pentru asanarea tubului digestiv şi tratamentul disbacteriozei
GEU20061256Y (en) Yoghurt
ES2155783A1 (es) Nueva utilizacion de lactobacillus casei para la preparacion de leches fermentadas para el tratamiento de niveles inmunitarios deprimidos.